Lactate-to-Albumin Ratio for Mortality Prediction in Severe Pancreatitis with ARDS

A retrospective study of 351 patients with severe acute pancreatitis and acute respiratory distress syndrome admitted to an intensive care unit from 2016 to 2024. The dataset, authored by Qingcheng Zhu and shared under a CC-BY-4.0 license, was used to evaluate the lactate-to-albumin ratio as a prognostic biomarker for in-hospital mortality.

Use Cases

• Build a mortality risk classifier based on the lactate-to-albumin ratio and other clinical variables.
• Benchmark the prognostic performance of the lactate-to-albumin ratio against established scores like SOFA.
• Identify threshold effects for clinical decision-making using the reported LAR cutoff of 1.78.
• Analyze the relationship between metabolic stress (lactate) and nutritional status (albumin) in critical illness outcomes.

Strengths

• Includes data from 351 patients, providing a substantial sample size for analysis.
• Study period spans 8 years (2016-2024), offering a contemporary clinical view.
• Results include specific statistical metrics (OR=1.32, 95% CI: 1.04–1.67) and a defined performance threshold (LAR=1.78).

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect geographic and institutional bias inherent to a single tertiary hospital study.

Provenance

Source

figshare

Collection Method

Retrospective study collecting clinical and laboratory data within 24 hours of ICU admission.

Time Range

2016 to 2024

Freshness

Last updated 2026-05-05 05:28:50; freshness should be verified.